Globus Medical is a medical device company that develops products for patients with musculoskeletal disorders. The firm's products are organized into two categories: innovative fusion and disruptive technologies. The innovative fusion products include fusion products that treat a variety of spinal disorders and can be used in several surgical applications. The disruptive technology products are used for applications such as minimally invasive surgery and new treatment alternatives, including motion preservation and regenerative biologic technologies. Globus Medical generates the vast majority of its revenue in the United States.
| Website: | www.globusmedical.com |
| Email: | investors@globusmedical.com |
| Main Phone: | +1 610 930-1800 |
| Address: | 2560 General Armistead Avenue |
| State: | PA |
| City / Town: | Audubon |
| Country: | USA |
| Postal Code: | 19403 |
| Exchange: | NYE |
| CEO: | David M. Demski |
| Employees: | 1500 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
| Last Price 45.79 | Change $ -1.68 | Change % -3.54 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open 47.20 | High 47.58 | Low 45.76 | Prev Close 47.47 |
| Last Trade | Volume 780,218 | 52 Wk Hi 57.83 | 52 Wk Low 38.01 |
| Market Cap 4.5 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 98,481,062.00 | EPS (TTM) 1.43 | PE Ratio 32.00 | Exchange NYSE |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 70 | 110 |
| Number of Buys | 22 | 42 |
| Number of Sells | 48 | 68 |
| Net Activity | -1171775 | -812734 |
| Last 10 Buys | Shares |
|---|---|
| N/A | 0 |
| Last 10 Sell | Shares |
|---|---|
| Steven M. Payne | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| David C. Paul | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 65 | 60 | 60 | 65 |
| Low Target Price Estimate | 37 | 37 | 37 | 37 |
| Mean Target Price Estimate | 55.78 | 54.5 | 54.5 | 55.78 |
| Standard Deviation | 7.97 | 7.56 | 7.56 | 7.97 |
| Date of Most Recent Estimate | 06/01/18 | 05/04/18 | 05/04/18 | 06/01/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-06-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-04 |
| SD | Specialized Disclosure Report | 3 | 2018-05-30 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 43 | 2018-05-03 |
| 8-K | Report of unscheduled material events or corporate changes. | 12 | 2018-05-02 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-04-30 |
| DEFA14A | Additional proxy soliciting materials - definitive | 4 | 2018-04-26 |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 51 | 2018-04-26 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-04-20 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 5 | 4 | 7 | 7 |
| Moderate Buy | 1 | 1 | 1 | 0 |
| Hold | 4 | 5 | 4 | 4 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 1 |
| Mean Rec. | 1.9 | 2.1 | 1.75 | 2 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
